Variant report
Variant | esv3360006 |
---|---|
Chromosome Location | chr5:61512895-61516093 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557619889 | chr5:61512899-61512900 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs572958572 | chr5:61512914-61512915 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539983450 | chr5:61512950-61512951 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs553324941 | chr5:61512954-61512955 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs573116572 | chr5:61513001-61513002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs61212542 | chr5:61513042-61513043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs554829902 | chr5:61513082-61513083 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs377371581 | chr5:61513092-61513093 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs370325160 | chr5:61513126-61513127 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs187168157 | chr5:61513132-61513133 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs375514042 | chr5:61513176-61513177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191670169 | chr5:61513188-61513189 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183724743 | chr5:61513197-61513198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs188215686 | chr5:61513245-61513246 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs56103269 | chr5:61513305-61513306 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs180761210 | chr5:61513307-61513308 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs545450699 | chr5:61513350-61513351 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs185695900 | chr5:61513357-61513358 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1895392 | chr5:61513405-61513406 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190219739 | chr5:61513443-61513444 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs528047320 | chr5:61513449-61513450 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs375130012 | chr5:61513457-61513458 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs4122299 | chr5:61513472-61513473 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs562226694 | chr5:61513625-61513626 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531256221 | chr5:61513642-61513643 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs551191512 | chr5:61513672-61513673 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs571094435 | chr5:61513681-61513682 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs540050610 | chr5:61513767-61513768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546733159 | chr5:61513785-61513786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs566980827 | chr5:61513825-61513826 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs565091079 | chr5:61513857-61513858 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs149066965 | chr5:61513861-61513862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs182135764 | chr5:61513881-61513882 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs574368258 | chr5:61513903-61513904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs555392759 | chr5:61513929-61513930 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs4081730 | chr5:61513931-61513932 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4081729 | chr5:61513934-61513935 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4081728 | chr5:61513943-61513944 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371024355 | chr5:61513946-61513947 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4081727 | chr5:61513963-61513964 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs577373307 | chr5:61513973-61513974 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs536996707 | chr5:61514045-61514046 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs4145850 | chr5:61514172-61514173 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs61690587 | chr5:61514173-61514174 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs34538633 | chr5:61514193-61514194 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs576581719 | chr5:61514202-61514203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs545615139 | chr5:61514215-61514216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs559149356 | chr5:61514232-61514233 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs4078712 | chr5:61514237-61514238 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs4078711 | chr5:61514258-61514259 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Gastric cancer | 22152101 | CNVD |
Oesophago-gastric ulcer | 22152101 | CNVD |
Ovarian cancer | 21781307 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
DNA damage stimulus | 22844521 | CNVD |
DNA repair | 22844521 | CNVD |
Breast cancer | 21785460 | CNVD |
Spinal muscular atrophy | 22422766 | CNVD |
Spinal muscular atrophy | 22558076 | CNVD |
Spinal muscular atrophy | 21320981 | CNVD |
Spinal muscular atrophy | 21762474 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Breast cancer | 22032731 | CNVD |
Prostate cancer | 21965145 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18694510 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Oral cancer | 21386901 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 19602461 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
abnormal development | 18461090 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 21364760 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroticism | 17667963 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:61512000-61517800 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr5:61513600-61514400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
3 | chr5:61514200-61515000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
4 | chr5:61515400-61515800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |